Streetbeat News

Stock Prices

MU

Deep-pocketed investors have shown a bearish sentiment towards Micron Technology (NASDAQ:MU), as revealed by Benzinga's options scanner. The scanner highlighted 113 extraordinary options activities, with 44% of investors leaning bearish. The trading volume for MU stands at 23,367,983, with the stock price up by 2.92% at $97.4. Analysts have a consensus target price of $145.0, with Keybanc maintaining an Overweight rating.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 8:45 pm

BOC

Boston Omaha (NYSE: BOC) reported Q2 earnings per share (EPS) of $(0.07), missing the analyst estimate of $(0.02) by 250%. However, the company reported sales of $27.09 million, beating the estimate of $26.60 million by 1.83%. Compared to the same period last year, EPS decreased by 240%, while sales increased by 11.86%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:43 pm

FOX

NWSA

NYT

TRI

Russia countered Ukraine's ground incursion into the Kursk region with missiles, drones, and airstrikes. Ukrainian forces had advanced into Russian territory, leading to a week-long battle. News organizations covering the war saw mixed stock movements.

Portfolio Pulse from Michael Juliano

August 13, 2024 | 8:43 pm

AGAE

Allied Gaming & Entertainment (NASDAQ: AGAE) reports that Knighted Pastures LLC is attempting to acquire control of AGAE without paying a control premium or constructively engaging with the board. Knighted's actions have led to litigation, causing AGAE to incur a one-time pre-tax expense of ~$3M for Q2 2024, negatively impacting net income and EPS.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:43 pm

CTSO

CytoSorbents (NASDAQ:CTSO) reported Q2 2024 GAAP EPS of $(0.08), beating the $(0.10) estimate. Sales were $9.89M, surpassing the $9.68M estimate and showing a 5.03% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:42 pm

XP

XP Inc. (NASDAQ:XP) reported Q2 2024 earnings per share (EPS) of $0.39, significantly missing the analyst consensus estimate of $1.91. The company also reported quarterly sales of $809.69 million, falling short of the $4.14 billion estimate. Despite the misses, sales increased by 12.93% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:42 pm

ELVA

Electrovaya (NASDAQ:ELVA) reported Q3 sales of $10.30 million, missing the analyst consensus estimate of $18.43 million by 44.10%. This represents a 2.19% decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:42 pm

ELTX

Elicio Therapeutics (NASDAQ:ELTX) reported a Q2 EPS of $(0.64), beating the analyst consensus estimate of $(0.96) by 33.33%. This represents a 75.48% improvement over the losses of $(2.61) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:40 pm

GOOG

GOOGL

Alphabet shares are trading lower following a report suggesting a bid to break up Google is one of the options being considered by the Justice Department.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:39 pm

CTNM

Contineum Therapeutics (NASDAQ:CTNM) reported a Q2 adjusted loss of $(0.39) per share, missing the analyst consensus estimate of $(0.35) by 11.43%. This represents a 146.43% decrease from the earnings of $0.84 per share in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:39 pm